Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?

  • Following the company's first-quarter earnings report, shares of Hims & Hers Health (HIMS 5.21%) opened the following day considerably lower, only to sprint higher once trading began. This action is just one example of why the stock is a bit of a divisive name among investors.